Literature DB >> 16515861

Sparks, signals and shock absorbers: how dystrophin loss causes muscular dystrophy.

Clare L Batchelor1, Steve J Winder.   

Abstract

The dystrophin-glycoprotein complex (DGC) can be considered as a specialized adhesion complex, linking the extracellular matrix to the actin cytoskeleton, primarily in muscle cells. Mutations in several components of the DGC lead to its partial or total loss, resulting in various forms of muscular dystrophy. These typically manifest as progressive wasting diseases with loss of muscle integrity. Debate is ongoing about the precise function of the DGC: initially a strictly mechanical role was proposed but it has been suggested that there is aberrant calcium handling in muscular dystrophy and, more recently, changes in MAP kinase and GTPase signalling have been implicated in the aetiology of the disease. Here, we discuss new and interesting developments in these aspects of DGC function and attempt to rationalize the mechanical, calcium and signalling hypotheses to provide a unifying hypothesis of the underlying process of muscular dystrophy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16515861     DOI: 10.1016/j.tcb.2006.02.001

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  47 in total

Review 1.  Syntrophins entangled in cytoskeletal meshwork: Helping to hold it all together.

Authors:  Sahar S Bhat; Roshia Ali; Firdous A Khanday
Journal:  Cell Prolif       Date:  2018-12-04       Impact factor: 6.831

2.  Duplex (or quadruplet) CH domain containing human multidomain proteins: an inventory.

Authors:  Felix Friedberg
Journal:  Mol Biol Rep       Date:  2009-06-30       Impact factor: 2.316

Review 3.  New insights in the regulation of calcium transfers by muscle dystrophin-based cytoskeleton: implications in DMD.

Authors:  Bruno Constantin; Stéphane Sebille; Christian Cognard
Journal:  J Muscle Res Cell Motil       Date:  2006-08-04       Impact factor: 2.698

4.  Preventing phosphorylation of dystroglycan ameliorates the dystrophic phenotype in mdx mouse.

Authors:  Gaynor Miller; Chris J Moore; Rebecca Terry; Tracy La Riviere; Andrew Mitchell; Robert Piggott; T Neil Dear; Dominic J Wells; Steve J Winder
Journal:  Hum Mol Genet       Date:  2012-07-18       Impact factor: 6.150

5.  CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors.

Authors:  Yue Jin; Yan Shen; Xuan Su; Neal Weintraub; Yaoliang Tang
Journal:  J Vis Exp       Date:  2019-09-14       Impact factor: 1.355

6.  Malformed mdx myofibers have normal cytoskeletal architecture yet altered EC coupling and stress-induced Ca2+ signaling.

Authors:  Richard M Lovering; Luke Michaelson; Christopher W Ward
Journal:  Am J Physiol Cell Physiol       Date:  2009-07-15       Impact factor: 4.249

Review 7.  Biological role of dystroglycan in Schwann cell function and its implications in peripheral nervous system diseases.

Authors:  Toshihiro Masaki; Kiichiro Matsumura
Journal:  J Biomed Biotechnol       Date:  2010-06-15

8.  Proteomic Profiling of the Dystrophin-Deficient MDX Heart Reveals Drastically Altered Levels of Key Metabolic and Contractile Proteins.

Authors:  Caroline Lewis; Harald Jockusch; Kay Ohlendieck
Journal:  J Biomed Biotechnol       Date:  2010-05-23

9.  Dystroglycan versatility in cell adhesion: a tale of multiple motifs.

Authors:  Chris J Moore; Steve J Winder
Journal:  Cell Commun Signal       Date:  2010-02-17       Impact factor: 5.712

10.  Prosurvival Factors Improve Functional Engraftment of Myogenically Converted Dermal Cells into Dystrophic Skeletal Muscle.

Authors:  Lindsey A Muir; Charles E Murry; Jeffrey S Chamberlain
Journal:  Stem Cells Dev       Date:  2016-09-07       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.